Lower abdominal and pelvic radiation and testicular germ cell tumor risk.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 02 03 2020
accepted: 04 09 2020
entrez: 11 11 2020
pubmed: 12 11 2020
medline: 22 12 2020
Statut: epublish

Résumé

Testicular germ cell tumor (TGCT) incidence has increased in recent decades along with the use and dose of diagnostic radiation. Here we examine the association between reported exposure to diagnostic radiation and TGCT risk. We conducted a case-control study of men with and without TGCT recruited from hospital- and population-based settings. Participants reported on exposures to 1) x-ray or CT below the waist and 2) lower GI series or barium enema, which consists of a series of x-rays of the colon. We also derived a combined measure of exposure. We used logistic regression to determine the risk of developing TGCT according to categories of exposures (0, 1-2, or ≥3 exposures) and age at first exposure, adjusting for age, year of birth, race, county, body mass index at diagnosis, family history of TGCT, and personal history of cryptorchidism. There were 315 men with TGCT and 931 men without TGCT in our study. Compared to no exposures, risk of TGCT was significantly elevated among those reporting at least three exposures to x-ray or CT (OR≥3 exposures, 1.78; 95% CI, 1.15-2.76; p = 0.010), lower GI series or barium enema (OR≥3 exposures, 4.58; 95% CI, 2.39-8.76; p<0.001), and the combined exposure variable (OR≥3 exposures, 1.59; 95% CI, 1.05-2.42; p = 0.029). The risk of TGCT was elevated for those exposed to diagnostic radiation at age 0-10 years, compared to those first exposed at age 18 years or later, although this association did not reach statistical significance (OR, 2.00; 95% CI, 0.91-4.42; p = 0.086). Exposure to diagnostic radiation below the waist may increase TGCT risk. If these results are validated, efforts to reduce diagnostic radiation doses to the testes should be prioritized.

Sections du résumé

BACKGROUND
Testicular germ cell tumor (TGCT) incidence has increased in recent decades along with the use and dose of diagnostic radiation. Here we examine the association between reported exposure to diagnostic radiation and TGCT risk.
METHODS
We conducted a case-control study of men with and without TGCT recruited from hospital- and population-based settings. Participants reported on exposures to 1) x-ray or CT below the waist and 2) lower GI series or barium enema, which consists of a series of x-rays of the colon. We also derived a combined measure of exposure. We used logistic regression to determine the risk of developing TGCT according to categories of exposures (0, 1-2, or ≥3 exposures) and age at first exposure, adjusting for age, year of birth, race, county, body mass index at diagnosis, family history of TGCT, and personal history of cryptorchidism.
RESULTS
There were 315 men with TGCT and 931 men without TGCT in our study. Compared to no exposures, risk of TGCT was significantly elevated among those reporting at least three exposures to x-ray or CT (OR≥3 exposures, 1.78; 95% CI, 1.15-2.76; p = 0.010), lower GI series or barium enema (OR≥3 exposures, 4.58; 95% CI, 2.39-8.76; p<0.001), and the combined exposure variable (OR≥3 exposures, 1.59; 95% CI, 1.05-2.42; p = 0.029). The risk of TGCT was elevated for those exposed to diagnostic radiation at age 0-10 years, compared to those first exposed at age 18 years or later, although this association did not reach statistical significance (OR, 2.00; 95% CI, 0.91-4.42; p = 0.086).
CONCLUSIONS
Exposure to diagnostic radiation below the waist may increase TGCT risk. If these results are validated, efforts to reduce diagnostic radiation doses to the testes should be prioritized.

Identifiants

pubmed: 33175879
doi: 10.1371/journal.pone.0239321
pii: PONE-D-20-04893
pmc: PMC7657535
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0239321

Subventions

Organisme : NCI NIH HHS
ID : U01 CA164947
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA114478
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Epidemiol Community Health. 1987 Dec;41(4):349-54
pubmed: 2901454
J Natl Cancer Inst. 1989 Sep 6;81(17):1307-12
pubmed: 2769783
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13761-6
pubmed: 14610281
AJR Am J Roentgenol. 2008 Feb;190(2):273-4
pubmed: 18212208
J Natl Compr Canc Netw. 2015 Jun;13(6):772-99
pubmed: 26085393
JAMA Pediatr. 2013 Aug 1;167(8):700-7
pubmed: 23754213
Lancet. 2012 Aug 4;380(9840):499-505
pubmed: 22681860
Br J Radiol. 2009 May;82(977):363-70
pubmed: 19386959
J Radiol Prot. 2010 Sep;30(3):389-406
pubmed: 20798474
Cancer. 2006 Mar 1;106(5):1169-77
pubmed: 16421921
Nat Genet. 2013 Jun;45(6):680-5
pubmed: 23666239
Eur Radiol. 2009 May;19(5):1156-60
pubmed: 19082601
Acta Oncol. 2010 May;49(4):447-53
pubmed: 20397774
Am J Epidemiol. 2013 Dec 1;178(11):1638-47
pubmed: 24008901
N Engl J Med. 2007 Nov 29;357(22):2277-84
pubmed: 18046031
Nat Commun. 2019 Mar 19;10(1):1260
pubmed: 30890710
Radiology. 2008 Jul;248(1):254-63
pubmed: 18566177
J Clin Epidemiol. 1990;43(1):87-91
pubmed: 2319285
Int J Androl. 2007 Aug;30(4):230-40; discussion 240-1
pubmed: 17488341
Br J Radiol. 2008 May;81(965):362-78
pubmed: 18440940
Dose Response. 2006 Aug 19;4(2):75-90
pubmed: 18648638
Spine (Phila Pa 1976). 2000 Aug 15;25(16):2052-63
pubmed: 10954636
Eur Urol. 2014 Jun;65(6):1095-106
pubmed: 24268506
Radiat Res. 1994 Feb;137(2 Suppl):S17-67
pubmed: 8127952
Nat Genet. 2010 May;42(5):410-4
pubmed: 20400964
Dose Response. 2010 Jan 18;8(2):172-91
pubmed: 20585444
N Engl J Med. 2009 Aug 27;361(9):849-57
pubmed: 19710483
J Clin Epidemiol. 2006 Oct;59(10):1087-91
pubmed: 16980149

Auteurs

Kevin T Nead (KT)

Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Department of Epidemiology, Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, United States of America.

Nandita Mitra (N)

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Benita Weathers (B)

Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Louisa Pyle (L)

Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Division of Human Genetics and Metabolism, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.

Nnadozie Emechebe (N)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, Florida, United States of America.

Donna A Pucci (DA)

Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Linda A Jacobs (LA)

Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

David J Vaughn (DJ)

Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Katherine L Nathanson (KL)

Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Peter A Kanetsky (PA)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH